SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

20 May 2024 Evaluate
The company's total revenue for the quarter ended March 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 2203.30 millions.The Net Loss for the quarter ended March 2024 is Rs. -440.73 millions as compared to Net Profit of Rs. 78.02 millions of corresponding quarter ended March 2023Operating profit Margin for the quarter ended March 2024 slipped to -200.95% as compared to 355.32% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2203.30 2181.59 1.00 7732.62 7894.36 -2.05 7732.62 7894.36 -2.05
Other Income 55.52 12.38 348.47 188.83 288.32 -34.51 188.83 288.32 -34.51
PBIDT -200.95 355.32 -156.55 460.13 1563.90 -70.58 460.13 1563.90 -70.58
Interest 138.76 133.81 3.70 543.26 569.42 -4.59 543.26 569.42 -4.59
PBDT -358.99 221.51 -262.06 -102.41 994.48 -110.30 -102.41 994.48 -110.30
Depreciation 127.83 107.17 19.28 493.90 328.21 50.48 493.90 328.21 50.48
PBT -486.82 114.34 -525.77 -596.31 666.27 -189.50 -596.31 666.27 -189.50
TAX -46.09 36.32 -226.90 -82.43 190.71 -143.22 -82.43 190.71 -143.22
Deferred Tax -39.81 6.01 -762.40 -82.43 51.51 -260.03 -82.43 51.51 -260.03
PAT -440.73 78.02 -664.89 -513.88 475.56 -208.06 -513.88 475.56 -208.06
Equity 167.47 157.09 6.61 167.47 157.09 6.61 167.47 157.09 6.61
PBIDTM(%) -9.12 16.29 -156.00 5.95 19.81 -69.96 5.95 19.81 -69.96

Camlin Fine Sciences Share Price

126.00 -0.97 (-0.76%)
04-May-2026 09:09 View Price Chart
Peers
Company Name CMP
BASF India 3691.95
Tata Chemicals 820.30
SRF 2524.90
Pidilite Inds. 1379.95
Deepak Nitrite 1740.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×